Cargando…
Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer
Lycorine, a natural alkaloid extracted from the Amaryllidaceae plant family, has been reported to exhibit a wide range of physiological effects, including the potential effect against cancer. However, the anti-prostate cancer (PCa) efficacy of Lycorine remains unrevealed. In this context, we figured...
Autores principales: | Hu, Meichun, Peng, Shihong, He, Yundong, Qin, Min, Cong, Xiaonan, Xing, Yajing, Liu, Mingyao, Yi, Zhengfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558156/ https://www.ncbi.nlm.nih.gov/pubmed/25915156 |
Ejemplares similares
-
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
por: He, Yundong, et al.
Publicado: (2016) -
Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122
por: Cong, Xiaonan, et al.
Publicado: (2021) -
Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
por: Shen, Jia, et al.
Publicado: (2018) -
A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer
por: Wang, Jinhua, et al.
Publicado: (2019) -
Ailanthone: a new potential drug for castration-resistant prostate cancer
por: Peng, Shihong, et al.
Publicado: (2017)